Skip to main content

Table 2 CMR imaging data of the study participants

From: Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure

  HF patients with low LVEF HF patients with normal LVEF Control subjects p value
(n = 25) (n = 23) (n = 21)
LV ejection fraction (%) 31.2 ± 12.3*, ** 60.2 ± 8.3 * 70.9 ± 7.6 <0.001
LV end-diastolic volume (mL) 169.5 ± 78.1*,** 124 ± 43.7 * 95.3 ± 23.4 < 0.001
LV end-systolic volume (mL) 120.8 ± 70.7*,** 51.2 ± 24.0 * 28.2 ± 11.5 < 0.001
Stroke volume (mL) 48.7 ± 19.4*,** 72.8 ± 22.4 67.2 ± 15.9 < 0.001
Cardiac output (L/min) 3.7 ± 1.5*,** 4.8 ± 1.5 5.1 ± 1.1 0.004
LV mass (g) 126.1 ± 52.9* 113.5 ± 34.8 * 94.4 ± 23.2 0.032
LV global function index (%) 20.2 ± 9.0*,** 37.6 ± 6.7 * 44.6 ± 6.1 < 0.001
LV concentricity 0.8 ± 0.3*,** 1.0 ± 0.4 1 ± 0.3 0.027
  1. Data are expressed as means ± standard deviations. P values are calculated from one-way analysis of variance
  2. Abbreviations: HF heart failure, LV left ventricle, LVEF left ventricular ejection fraction
  3. * p < 0.05 vs. controls; ** p < 0.05 vs. HF patients with normal LVEF